LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)Alexander Stein, Mascha Binder, Joseph Tintelnot et al.|Annals of Oncology|2021Cited by 10